Search COVID-19 Rapid Resource Center or explore resources sorted by Category or Content Type.

 

Category: Epidemiology Outcomes

Characterization and Outcomes of Hospitalized Children With Coronavirus Disease 2019: A Report From a Multicenter, Viral Infection and Respiratory Illness Universal Study (Coronavirus Disease 2019) Registry

From Critical Care Medicine . In this observational, multicenter registry of children with coronavirus disease 2019, the authors found that ICU admission was common. Older age, fever, multisystem inflammatory syndrome in children, and seizure disorder were independently assoc...

   Estimated Time: 33:07 min Coronavirus, COVID-19, pediatrics

Long-Term Acute Care Hospital Outcomes of Mechanically Ventilated Patients With Coronavirus Disease 2019

From Critical Care Medicine . In this study, the authors reported that most patients with coronavirus disease 2019 transferred to two Chicago-area long-term acute care hospitals successfully weaned from prolonged mechanical ventilation.

   Estimated Time: 22:35 min Coronavirus, COVID-19, Ventilatory Support

Body Mass Index and Mortality in Coronavirus Disease 2019 and Other Diseases: A Cohort Study in 35,506 ICU Patients

From Critical Care Medicine . The authors concluded that, the obesity paradox, which is the inverse J-shaped association between BMI and mortality in critically ill patients, is not present in critically ill patients with COVID-19–related respiratory failure in contrast to no...

   Estimated Time: 26:57 min Coronavirus, COVID-19

Trends in ICU Mortality From Coronavirus Disease 2019: A Tale of Three Surges

From Critical Care Medicine . The authors sought to determine the association between time period of hospitalization and hospital mortality among critically ill adults with coronavirus disease 2019.

   Estimated Time: 28:02 min Coronavirus, COVID-19

Trends in 28-Day Mortality of Critical Care Patients With Coronavirus Disease 2019 in United Kingdom: A National Cohort Study, March 2020 to January 2021

From Critical Care Medicine . The authors sought to determine whether the previously described trend of improving mortality in people with coronavirus disease 2019 in critical care during the first wave was maintained, plateaued, or reversed during the second wave in United K...

   Estimated Time: 16:08 min Coronavirus, COVID-19, Statistics

Empirical Assessment of U.S. Coronavirus Disease 2019 Crisis Standards of Care Guidelines

From Critical Care Explorations.  The authors found that this proof-of-principle study demonstrates the feasibility and importance of empirical testing of crisis standards of care guidelines to understand whether they meet their goals.

   Estimated Time: 26:22 min Coronavirus, COVID-19

Epidemiological and Clinical Characterization of Superinfections in Critically Ill Coronavirus Disease 2019 Patients

From Critical Care Explorations . Prevalence of superinfections in coronavirus disease 2019 patients requiring mechanical ventilation was high in this series, and bacterial superinfections were independently associated with ICU or 28-day mortality (whichever comes first).

   Estimated Time: 23:15 min Coronavirus, COVID-19, Ventilatory Support

Outcome Improvement Between the First Two Waves of the Coronavirus Disease 2019 Pandemic in a Single Tertiary-Care Hospital in Belgium

From Critical Care Explorations .  In this article, the authors note that the main therapeutic changes between the first wave of the coronavirus disease 2019 pandemic and the second wave of the coronavirus disease 2019 pandemic were use of steroids, unrestrictive use of high-...

   Estimated Time: 26:34 min Coronavirus, COVID-19

Characteristics, Comorbidities, Complications, and Outcomes Among 802 Patients With Severe Acute Respiratory Syndrome Coronavirus 2 in a Community Hospital in Florida

From Critical Care Explorations .  In this study, the authors reviewed the demographics, characteristics, comorbidities, complications, and outcomes of hospitalized patients with severe acute respiratory syndrome coronavirus 2, and their association with mortality at medical ...

   Estimated Time: 23:03 min Comorbidities, Coronavirus, COVID-19

Coronavirus Disease 2019 ICU Patients Have Higher-Than-Expected Acute Physiology and Chronic Health Evaluation–Adjusted Mortality and Length of Stay Than Viral Pneumonia ICU Patients

From Critical Care Medicine . The authors compared APACHE-IV–adjusted mortality and length of stay outcomes of adult ICU patients who tested positive for coronavirus disease 2019 with patients admitted to ICU with other viral pneumonias.

   Estimated Time: 12:03 min Coronavirus, COVID-19, Ventilatory Support

Editorial: Capacity Strain and Response During Coronavirus Disease 2019: One Size Does Not Fit All, and One Size Does Not Fit One

From Critical Care Medicine . In this editorials, the authors discuss hospital preparedness in the article "Variation in Initial U.S. Hospital Responses to the Coronavirus Disease 2019 Pandemic."

   Estimated Time: 10:28 min Coronavirus, COVID-19, Disaster Preparedness

Surge and Mortality in ICUs in New York City’s Public Healthcare System

From Critical Care Medicine . The authors evaluate the impact of ICU surge on mortality and to explore clinical and sociodemographic predictors of mortality.

   Estimated Time: 26:12 min Coronavirus, COVID-19, Statistics

Editorial: The Complex Issue of Race and Coronavirus Disease 2019 in the ICU

From Critical Care Medicine . In this editorial, the authors discuss the article Racial Differences in a Detroit, MI, ICU Population of Coronavirus Disease 2019 Patients by Lazar et al. about healthcare inequalities and  disparate outcomes.

   Estimated Time: 11:19 Coronavirus, COVID-19

The Effects of ICU Crisis Reorganization on Outcomes in Patients Not Infected With Coronavirus Disease 2019 During the Initial Surge of the Coronavirus Disease 2019 Pandemic

From Critical Care Explorations . In this study, the authors determined if ICU reorganization due to the coronavirus disease 2019 pandemic affected outcomes in critically ill patients who were not infected with coronavirus disease 2019.

   Estimated Time: 16:52 Coronavirus, COVID-19, Resource Allocation

Tocilizumab in Coronavirus Disease 2019-Related Critical Illness: A Propensity Matched Analysis

From Critical Care Explorations .  In this study, the authors evaluate ICU mortality at 28 days in patients with severe hypoxemic respiratory failure due to coronavirus disease 2019 infection who received tocilizumab. 

   Estimated Time: 33:18

The Impact of the Novel Coronavirus on Brazilian PICUs

From Pediatric Critical Care Medicine.  The authors evaluated the impact of the coronavirus disease 2019 pandemic, considering the physical distancing and schools closing, on the characteristics of admission and epidemiology on Brazilian PICUs.  

   Estimated Time: 13:08 Coronavirus, COVID-19, pediatrics

Tokyo and New York: A Study in the Contrasting Effects of Socioeconomic Status on Coronavirus Disease 2019 Outcomes

From Critical Care Explorations.  The authors examined the association between socioeconomic status and the rate of coronavirus disease 2019 infections using public data from Tokyo.

   Estimated Time: 9:57 Coronavirus, COVID-19, Infection Control, Statistics

Nationwide Incidence and Outcomes of Patients With Coronavirus Disease 2019 Requiring Intensive Care in Iceland

From Critical Care Medicine. In this study from Iceland, which had early adoption of widespread testing, the authors report a lower overall ratio of ICU admissions for coronavirus disease 2019 among severe acute respiratory syndrome coronavirus 2 positive patients and a lower ...

   Estimated Time: 10:24 min Coronavirus, COVID-19, Statistics

How effective are medications that target interleukin-6?

Questions from social media, blogs and the various discussion forums, including the new SCCM COVID-19 Discussion Group, were answered. This microlearning content was taken from the COVID-19 Critical Care for Non-ICU Clinicians: Expert Panel Series held on June 10th, 2020.

   Estimated Time: 01:57 min Coronavirus, COVID-19, Therapies

Less Can Be More When Targeting Interleukin-6-Mediated Cytokine Release Syndrome in Coronavirus Disease 2019

Cytokine release syndrome (CRS) mediated by IL-6 is a critical driver of COVID-19 mortality. The authors review and discuss key immunologic effects of direct IL-6 blockade, downstream non-selective JAK inhibition, and selective JAK2 suppression to treat COVID-19-related CRS.

   Estimated Time: 12:04 min Comorbidities, Coronavirus, COVID-19, Diagnosis and Testing